aldosterone has been researched along with Coronary Disease in 60 studies
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten patients with severe chronic heart failure were given prazosin 5 mg and captopril 25 mg in random order on consecutive days." | 9.05 | Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects. ( Coxon, R; Sharpe, DN, 1982) |
| "To address this question, we examined data from the dal-OUTCOMES trial that compared the cholesteryl ester transfer protein inhibitor dalcetrapib with placebo, beginning 4 to 12 weeks after an index acute coronary syndrome." | 7.85 | Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure. ( Ballantyne, CM; Barter, PJ; Gunzburger, E; Kallend, D; Kittelson, J; Leiter, LA; Leitersdorf, E; McMurray, JJ; Nicholls, SJ; Olsson, AG; Pitts, R; Schwartz, GG; Shah, PK; Tardif, JC, 2017) |
| " This study determined whether myocardial aldosterone and angiotensin II release occurs in patients with aortic stenosis (AS) and/or coronary heart disease (CHD) with normal left ventricular ejection fractions and no clinical heart failure." | 7.73 | Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease. ( Richards, AM; Stewart, RA; Wasywich, CA; Webster, MW, 2006) |
| "The possible role of angiotensin-converting enzyme inhibition in preventing or minimizing tolerance to intravenous nitroglycerin in severe congestive heart failure (CHF) was studied by quantitating the degree of tolerance in 12 patients receiving nitroglycerin (group 1) and in 9 patients (group 2) receiving nitroglycerin and concurrent treatment with captopril (60 +/- 29 mg/day)." | 7.68 | Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease. ( Dakak, N; Flugelman, MY; Halon, DA; Lewis, BS; Makhoul, N; Merdler, A; Schneeweiss, A; Shehadeh, H, 1990) |
| "Ten patients with severe chronic heart failure were given prazosin 5 mg and captopril 25 mg in random order on consecutive days." | 5.05 | Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects. ( Coxon, R; Sharpe, DN, 1982) |
| "To address this question, we examined data from the dal-OUTCOMES trial that compared the cholesteryl ester transfer protein inhibitor dalcetrapib with placebo, beginning 4 to 12 weeks after an index acute coronary syndrome." | 3.85 | Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure. ( Ballantyne, CM; Barter, PJ; Gunzburger, E; Kallend, D; Kittelson, J; Leiter, LA; Leitersdorf, E; McMurray, JJ; Nicholls, SJ; Olsson, AG; Pitts, R; Schwartz, GG; Shah, PK; Tardif, JC, 2017) |
| " This study determined whether myocardial aldosterone and angiotensin II release occurs in patients with aortic stenosis (AS) and/or coronary heart disease (CHD) with normal left ventricular ejection fractions and no clinical heart failure." | 3.73 | Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease. ( Richards, AM; Stewart, RA; Wasywich, CA; Webster, MW, 2006) |
| "The possible role of angiotensin-converting enzyme inhibition in preventing or minimizing tolerance to intravenous nitroglycerin in severe congestive heart failure (CHF) was studied by quantitating the degree of tolerance in 12 patients receiving nitroglycerin (group 1) and in 9 patients (group 2) receiving nitroglycerin and concurrent treatment with captopril (60 +/- 29 mg/day)." | 3.68 | Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease. ( Dakak, N; Flugelman, MY; Halon, DA; Lewis, BS; Makhoul, N; Merdler, A; Schneeweiss, A; Shehadeh, H, 1990) |
| "Treatment with prazosin for one month also reduced systemic vascular resistance by 8%, renal vascular resistance increased by 20%, and renal blood flow and the percentage of the cardiac output going to the kidney fell by 14% and 26%." | 2.66 | The renal response to neuroendocrine inhibition in chronic heart failure: double-blind comparison of captopril and prazosin. ( Bayliss, J; Canepa-Anson, R; Norell, M; Poole-Wilson, P; Sutton, G, 1986) |
| "Beneficial effects of anti-aldosterone treatment in heart failure may thus be secondary in part to blockade of cardiac aldosterone action." | 2.42 | Aldosterone-synthase overexpression in heart: a tool to explore aldosterone's effects. ( Ambroisine, ML; Bendall, JK; Delcayre, C; Fuchs, S; Garnier, A; Heymes, C; Milliez, P; Nehme, J; Robidel, E; Swynghedauw, B, 2004) |
| "Spironolactone was less effective, and aldosterone tended to exert opposite effects on coronary artery structure after angioplasty." | 1.31 | Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries. ( Bobik, A; Funder, J; Kanellakis, P; Ramsey, D; Ward, MR, 2001) |
| "Aldosterone treatment was associated with a decrease in renin activity and a non-significant increase in mean arterial pressure." | 1.29 | Neointimal thickening after balloon denudation is enhanced by aldosterone and inhibited by spironolactone, and aldosterone antagonist. ( Bauters, C; Bertrand, ME; Dupuis, B; Hamon, M; Lablanche, JM; McFadden, EP; Racadot, A; Van Belle, E; Wernert, N, 1995) |
| "In the chronic respiratory failure group there was no change in blood gases, mean pulmonary arterial pressure or pulmonary vascular resistance." | 1.27 | Effects of captopril on pulmonary haemodynamics. ( Auzépy, P; Conrad, M; Richard, C; Ricome, JL; Rimailho, A, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (60.00) | 18.7374 |
| 1990's | 11 (18.33) | 18.2507 |
| 2000's | 7 (11.67) | 29.6817 |
| 2010's | 5 (8.33) | 24.3611 |
| 2020's | 1 (1.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X | 1 |
| Zhang, F | 1 |
| Zhou, H | 1 |
| Hu, Y | 1 |
| Guo, D | 1 |
| Fang, X | 1 |
| Chen, Y | 1 |
| Erne, P | 1 |
| Müller, A | 1 |
| Rossi, GP | 1 |
| Seifert, B | 1 |
| Stehlin, F | 1 |
| Redondo, M | 1 |
| Bauer, PT | 1 |
| Kobza, R | 1 |
| Resink, TJ | 1 |
| Radovanovic, D | 1 |
| Joseph, JJ | 1 |
| Echouffo-Tcheugui, JB | 1 |
| Kalyani, RR | 1 |
| Yeh, HC | 1 |
| Bertoni, AG | 1 |
| Effoe, VS | 1 |
| Casanova, R | 1 |
| Sims, M | 1 |
| Wu, WC | 1 |
| Wand, GS | 1 |
| Correa, A | 1 |
| Golden, SH | 1 |
| Resic, N | 1 |
| Durak-Nalbantic, A | 1 |
| Dzubur, A | 1 |
| Begic, A | 1 |
| Begic, E | 1 |
| Maslov, LN | 1 |
| Naryzhnaia, NV | 1 |
| Pitts, R | 1 |
| Gunzburger, E | 1 |
| Ballantyne, CM | 1 |
| Barter, PJ | 1 |
| Kallend, D | 1 |
| Leiter, LA | 1 |
| Leitersdorf, E | 1 |
| Nicholls, SJ | 1 |
| Shah, PK | 1 |
| Tardif, JC | 1 |
| Olsson, AG | 1 |
| McMurray, JJ | 1 |
| Kittelson, J | 1 |
| Schwartz, GG | 1 |
| Rocha, R | 1 |
| Martin-Berger, CL | 1 |
| Yang, P | 1 |
| Scherrer, R | 1 |
| Delyani, J | 1 |
| McMahon, E | 1 |
| Ohbayashi, Y | 1 |
| Tsutamoto, T | 1 |
| Sakaguchi, T | 1 |
| Tanaka, T | 1 |
| Kanamori, T | 1 |
| Yokohama, H | 1 |
| Sichiri, G | 1 |
| Hukai, D | 1 |
| Okabayashi, T | 1 |
| Ozawa, T | 1 |
| Ishii, C | 1 |
| Tsutsui, T | 1 |
| Ohno, K | 1 |
| Ohnishi, M | 1 |
| Wada, A | 1 |
| Heymes, C | 1 |
| Garnier, A | 1 |
| Fuchs, S | 1 |
| Bendall, JK | 1 |
| Nehme, J | 1 |
| Ambroisine, ML | 2 |
| Robidel, E | 1 |
| Swynghedauw, B | 1 |
| Milliez, P | 1 |
| Delcayre, C | 2 |
| Pitt, B | 1 |
| Wasywich, CA | 1 |
| Webster, MW | 1 |
| Richards, AM | 1 |
| Stewart, RA | 1 |
| Favre, J | 1 |
| Oliviero, P | 1 |
| Rodriguez, C | 1 |
| Gao, J | 1 |
| Thuillez, C | 1 |
| Samuel, JL | 1 |
| Richard, V | 1 |
| Thurau, K | 1 |
| Miagkaia, IP | 1 |
| Iakovlev, AA | 1 |
| Schneider, W | 1 |
| Kuhn-Fetzer, A | 1 |
| Rosak, C | 1 |
| Hoffmann, G | 1 |
| Jungmann, E | 1 |
| Böhmer, D | 1 |
| Bussmann, WD | 1 |
| Kaltenbach, M | 1 |
| Ali, AS | 1 |
| Richard, C | 1 |
| Ricome, JL | 1 |
| Rimailho, A | 1 |
| Conrad, M | 1 |
| Auzépy, P | 1 |
| Prys-Roberts, C | 1 |
| Prum, IA | 1 |
| Lishmanov, IuB | 1 |
| Slepushkin, VD | 1 |
| Korkushko, OV | 2 |
| Kalinovskaia, EG | 1 |
| Asinova, MI | 1 |
| Sharpe, DN | 1 |
| Coxon, R | 1 |
| Stasiński, T | 1 |
| Lehmann, Z | 1 |
| Kostka-Wach, M | 1 |
| Biryńczyk, J | 1 |
| Warenik-Szymankiewicz, A | 1 |
| Gerasimov, GM | 2 |
| Martyniuk, AD | 2 |
| Egan, BM | 1 |
| Stepniakowski, K | 1 |
| Goodfriend, TL | 1 |
| Van Belle, E | 1 |
| Bauters, C | 1 |
| Wernert, N | 1 |
| Hamon, M | 1 |
| McFadden, EP | 1 |
| Racadot, A | 1 |
| Dupuis, B | 1 |
| Lablanche, JM | 1 |
| Bertrand, ME | 1 |
| Mitrovic, V | 1 |
| Oehm, E | 1 |
| Minge, C | 1 |
| Thürmann, P | 1 |
| Schlepper, M | 1 |
| Pasaoglu, I | 1 |
| Erbas, B | 1 |
| Varoglu, E | 1 |
| Yorgancioglu, C | 1 |
| Hazan, E | 1 |
| Koray, Z | 1 |
| Bekdik, C | 1 |
| Bozer, YA | 1 |
| Motwani, JG | 1 |
| Fenwick, MK | 1 |
| Morton, JJ | 1 |
| Struthers, AD | 1 |
| Münzel, T | 1 |
| Heitzer, T | 1 |
| Kurz, S | 1 |
| Harrison, DG | 1 |
| Luhman, C | 1 |
| Pape, L | 1 |
| Olschewski, M | 1 |
| Just, H | 1 |
| Ebel, H | 1 |
| Laage, C | 1 |
| Keuchel, M | 1 |
| Dittmar, A | 1 |
| Saure, B | 1 |
| Ehlenz, K | 1 |
| Lange, H | 1 |
| Braith, RW | 1 |
| Welsch, MA | 1 |
| Feigenbaum, MS | 1 |
| Kluess, HA | 1 |
| Pepine, CJ | 1 |
| Ward, MR | 1 |
| Kanellakis, P | 1 |
| Ramsey, D | 1 |
| Funder, J | 1 |
| Bobik, A | 1 |
| Malaia, LT | 1 |
| Rachinskiĭ, ID | 2 |
| Shushliapin, OI | 3 |
| Sidorenko, BA | 1 |
| Kudisov, IuM | 1 |
| Rossel's, AN | 1 |
| Razumova, ET | 1 |
| Drozdova, ES | 1 |
| Nosova, NP | 1 |
| Kazanova, LR | 1 |
| Ubrantsev, VA | 1 |
| Kannel, WB | 1 |
| Sadulaeva, LM | 1 |
| Speranskaia, NV | 1 |
| Levitskaia, IuV | 1 |
| Vlasenko, MA | 1 |
| Prachar, H | 2 |
| Ogris, E | 1 |
| Dittel, M | 1 |
| Enenkel, W | 1 |
| Dakak, N | 1 |
| Makhoul, N | 1 |
| Flugelman, MY | 1 |
| Merdler, A | 1 |
| Shehadeh, H | 1 |
| Schneeweiss, A | 1 |
| Halon, DA | 1 |
| Lewis, BS | 1 |
| Crozier, IG | 1 |
| Ikram, H | 1 |
| Nicholls, MG | 1 |
| Dudaev, VA | 1 |
| Diukov, IV | 1 |
| Borodkin, VV | 1 |
| Gorin, VV | 1 |
| Mironova, MA | 1 |
| Frolkis, MV | 1 |
| Yaroshenko, YT | 1 |
| Bayliss, J | 1 |
| Canepa-Anson, R | 1 |
| Norell, M | 1 |
| Poole-Wilson, P | 1 |
| Sutton, G | 1 |
| Ena, P | 1 |
| Madeddu, P | 1 |
| Glorioso, N | 1 |
| Cerimele, D | 1 |
| Rappelli, A | 1 |
| Koshu, M | 1 |
| Sugimoto, T | 1 |
| Terada, Y | 1 |
| Uraoka, T | 1 |
| Serebrovskaia, IuA | 1 |
| Vinogradov, AV | 3 |
| Uchitel', IA | 1 |
| Arora, RB | 1 |
| Yoshitake, T | 1 |
| Mizuno, A | 1 |
| Saigusa, M | 1 |
| Kato, T | 1 |
| Weil, MH | 1 |
| Shubin, H | 1 |
| Sycheva, IM | 2 |
| Kuz'mina, AE | 1 |
| Kiseleva, ZM | 1 |
| Landau, RL | 1 |
| Poulos, JT | 1 |
| Berman, EI | 1 |
| Manta, I | 1 |
| Hodîrnău, A | 1 |
| Proinov, I | 1 |
| Băltescu, V | 1 |
| Schneider, E | 1 |
| Kaufmann, W | 1 |
| Steiner, B | 1 |
| Dürr, F | 1 |
| Nieth, H | 1 |
| Behn, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Mineralcorticoid Recept Antagonist on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia：A Multicenter Randomized Controlled Study[NCT05688579] | Phase 4 | 8,000 participants (Anticipated) | Interventional | 2023-04-16 | Enrolling by invitation | ||
| A Randomized, Double-blind, Placebo-controlled Study Assessing the Effect of RO4607381 on Cardiovascular Mortality and Morbidity in Clinically Stable Patients With a Recent Acute Coronary Syndrome[NCT00658515] | Phase 3 | 15,871 participants (Actual) | Interventional | 2008-04-30 | Completed | ||
| Effectiveness of Combined Aerobic and Strength Training in Acute and Chronic Adaptations in Patients With Heart Failure[NCT03320655] | 28 participants (Actual) | Interventional | 2017-10-09 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00658515)
Timeframe: At 53 Months
| Intervention | mg/dL (Least Squares Mean) |
|---|---|
| Dalcetrapib (RO4607381) | 44.96 |
| Placebo | 15.60 |
(NCT00658515)
Timeframe: Throughout Study, up to 53 Months
| Intervention | Participants (Count of Participants) |
|---|---|
| Dalcetrapib (RO4607381) | 226 |
| Placebo | 229 |
Number of cardiovascular events per patient per year (NCT00658515)
Timeframe: From date of randomization to first event up to 48 months
| Intervention | Event per Patient Years of Followup (Number) |
|---|---|
| Dalcetrapib (RO4607381) | 0.034050 |
| Placebo | 0.032759 |
5 reviews available for aldosterone and Coronary Disease
| Article | Year |
|---|---|
Aldosterone-synthase overexpression in heart: a tool to explore aldosterone's effects.
Topics: Aldosterone; Animals; Coronary Disease; Cytochrome P-450 CYP11B2; Female; Gene Expression Regulation | 2004 |
Pathophysiology of hypertension and ischemic heart disease.
Topics: Adult; Aldosterone; Animals; Cardiomegaly; Coronary Circulation; Coronary Disease; Endocardium; Hear | 1980 |
[Effect of oral contraceptives on the circulatory system].
Topics: Aldosterone; Angiotensin II; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Ora | 1980 |
Shock following acute myocardial infarction. Current understanding of hemodynamic mechanisms.
Topics: Acidosis; Aldosterone; Animals; Arrhythmias, Cardiac; Arteries; Blood Flow Velocity; Blood Pressure; | 1968 |
The metabolic influence of progestins.
Topics: Aldosterone; Amino Acids; Anabolic Agents; Carbon Dioxide; Clinical Trials as Topic; Contraceptives, | 1971 |
9 trials available for aldosterone and Coronary Disease
| Article | Year |
|---|---|
Effect of an angiotensin II type 1 receptor blocker, valsartan, on neurohumoral factors in patients with hypertension: comparison with a long-acting calcium channel antagonist, amlodipine.
Topics: Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Co | 2003 |
Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
Topics: Aged; Aldosterone; Blood Pressure; Captopril; Chronic Disease; Clinical Trials as Topic; Coronary Di | 1982 |
[Anti-ischemia effects of gallopamil and esmolol in an intra-individual comparison in patients with coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Aldosterone; Atrial Natriuretic Factor; Coronary Angiography; Cor | 1994 |
Determinants of the initial effects of captopril on blood pressure, glomerular filtration rate, and natriuresis in mild-to-moderate chronic congestive heart failure secondary to coronary artery disease.
Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Captopril; Coronary Di | 1994 |
Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease.
Topics: Aldosterone; Case-Control Studies; Coronary Angiography; Coronary Disease; Coronary Vessels; Dose-Re | 1996 |
Neuroendocrine activation in heart failure is modified by endurance exercise training.
Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Coronary Disease; Exercise; Female; He | 1999 |
[Use of the aldosterone antagonist, canrenoate potassium for treating chronic circulatory insufficiency].
Topics: Adult; Aged; Aldosterone; Canrenoic Acid; Cardiovascular Diseases; Chronic Disease; Clinical Trials | 1979 |
The renal response to neuroendocrine inhibition in chronic heart failure: double-blind comparison of captopril and prazosin.
Topics: Aged; Aldosterone; Captopril; Cardiac Output; Cardiomyopathy, Dilated; Coronary Disease; Double-Blin | 1986 |
The metabolic influence of progestins.
Topics: Aldosterone; Amino Acids; Anabolic Agents; Carbon Dioxide; Clinical Trials as Topic; Contraceptives, | 1971 |
47 other studies available for aldosterone and Coronary Disease
| Article | Year |
|---|---|
Interplay of TNF-α, soluble TNF receptors and oxidative stress in coronary chronic total occlusion of the oldest patients with coronary heart disease.
Topics: Aged, 80 and over; Aldosterone; Angiotensin II; Biomarkers; C-Reactive Protein; Cohort Studies; Coro | 2020 |
Aldosterone and renin in cardiac patients referred for catheterization.
Topics: Aldosterone; Biomarkers; Cardiac Catheterization; Coronary Disease; Humans; Luminescent Measurements | 2017 |
Aldosterone, Renin, Cardiovascular Events, and All-Cause Mortality Among African Americans: The Jackson Heart Study.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Black or African American; Body Mass Index; Cardiovascu | 2017 |
Serum Aldosterone as Predictor of Progression of Coronary Heart Disease in Patients Without Signs of Heart Failure After Acute Myocardial Infarction.
Topics: Aged; Aldosterone; Biomarkers; Coronary Disease; Disease Progression; Female; Follow-Up Studies; Hum | 2018 |
[IMPACT OF LONG-TERM ADAPTATION TO COLD ON THE STATE OF CARDIOVASCULAR SYSTEM].
Topics: Acclimatization; Adaptation, Physiological; Aldosterone; Angiotensin II; Animals; Arctic Regions; Ca | 2015 |
Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure.
Topics: Acute Coronary Syndrome; Aged; Aldosterone; Amides; Angina, Unstable; Anticholesteremic Agents; Card | 2017 |
Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Body Weight; Coronary Disease; Coronary Vessels | 2002 |
A new HOPE for aldosterone blockade?
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2004 |
Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease.
Topics: Aged; Aldosterone; Angiotensin II; Aorta; Aortic Valve Stenosis; Coronary Disease; Female; Humans; M | 2006 |
Aldosterone-induced coronary dysfunction in transgenic mice involves the calcium-activated potassium (BKCa) channels of vascular smooth muscle cells.
Topics: Aldosterone; Animals; Cells, Cultured; Coronary Disease; Male; Mice; Mice, Transgenic; Muscle, Smoot | 2007 |
[Fundamental research].
Topics: Adrenergic beta-Antagonists; Aldosterone; Animals; Biological Transport; Cats; Cerebral Arteries; Co | 1980 |
[Aldosterone content of the blood in ischemic heart disease under antireticular cytotoxic serum treatment].
Topics: Adult; Aldosterone; Coronary Disease; Female; Humans; Hypertension; Immune Sera; Immunization, Passi | 1982 |
[Behavior of the lactate level during comparative ergometric stress tests with step climbing and the bicycle ergometer].
Topics: Adult; Aged; Aldosterone; Angina Pectoris; Cardiac Output; Coronary Disease; Exercise Test; Female; | 1983 |
[Renin-angiotensin-aldosterone system of elderly patients suffering from chronic ischemic heart disease].
Topics: Aged; Aldosterone; Chronic Disease; Coronary Disease; Humans; Middle Aged; Potassium; Renin; Renin-A | 1984 |
Effects of captopril on pulmonary haemodynamics.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Captopril; Cardiac Output; Coronary Disease; Female; Heart | 1984 |
[Effect of enkephalins on vasopressin and aldosterone levels in acute experimental myocardial ischemia].
Topics: Aldosterone; Animals; Coronary Disease; Diuresis; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine | 1984 |
[Renin activity and aldosterone levels in the blood plasma in chronic ischemic heart disease in the elderly].
Topics: Adult; Aged; Aging; Aldosterone; Chronic Disease; Coronary Disease; Humans; Middle Aged; Renin; Reni | 1982 |
[Use of a radioimmunological study sequence for elucidating the role of vasopressor factors in the pathogenesis of hypertension].
Topics: Adult; Aldosterone; Chronic Disease; Coronary Disease; Humans; Hydrocortisone; Hypertension; Male; M | 1981 |
Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering.
Topics: Adult; Aldosterone; Anthropometry; Blood Pressure; Cluster Analysis; Coronary Disease; Diet; Diet, S | 1994 |
Neointimal thickening after balloon denudation is enhanced by aldosterone and inhibited by spironolactone, and aldosterone antagonist.
Topics: Aldosterone; Angioplasty, Balloon; Animals; Aorta; Blood Pressure; Coronary Disease; Iliac Artery; R | 1995 |
Changes in the circulating endothelin and atrial natriuretic peptide levels during coronary artery bypass surgery.
Topics: Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Coronary Artery Bypass; Coronary Disease; En | 1993 |
Impact of profile haemodialysis on intra-/extracellular fluid shifts and the release of vasoactive hormones in elderly patients on regular dialysis treatment.
Topics: Aged; Aging; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Coronary Disease; | 1997 |
Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries.
Topics: Aldosterone; Angioplasty, Balloon; Animals; Collagen; Constriction, Pathologic; Coronary Disease; Co | 2001 |
[State of the neurohumoral regulatory system in circulatory insufficiency].
Topics: 17-Ketosteroids; Adult; Aged; Aldosterone; Angiotensinogen; Coronary Disease; Cortisone; Endopeptida | 1976 |
[Disorder of the mineralocorticoid function of the adrenals in the acute period of myocardial infarct and the ways for its correction].
Topics: Acute Disease; Adrenal Gland Diseases; Adult; Aged; Aldosterone; Chronic Disease; Coronary Disease; | 1979 |
[Renin activity and adrenal functional indices in chronic circulatory insufficiency].
Topics: Adrenal Glands; Adult; Aldosterone; Cardiovascular Diseases; Chronic Disease; Coronary Disease; Epin | 1979 |
[Renin activity and the aldosterone and cortisol content in the blood depending on the course of hypertension].
Topics: Adult; Aldosterone; Blood Pressure; Chronic Disease; Coronary Disease; Enzyme Activation; Humans; Hy | 1979 |
[State of the renin-angiotensin-aldosterone system in chronic circulatory insufficiency].
Topics: Aldosterone; Angiotensin II; Chronic Disease; Coronary Disease; Humans; Renin | 1978 |
Role of blood pressure in cardiovascular disease: the Framingham Study.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Cardiovascular Diseases; Cholesterol; Coronary Disease; De | 1975 |
[Disorders of electrolyte balance in patients with coronary atherosclerosis].
Topics: Adult; Aldosterone; Arteriosclerosis; Cholesterol; Coronary Disease; Humans; Hypernatremia; Male; Mi | 1975 |
[Renin-angiotensin-aldosterone system in hypertensive disease and arteriosclerotic myocardioslcerosis complicated by chronic circulatory insufficiency].
Topics: Aged; Aldosterone; Angiotensin II; Blood Circulation; Chronic Disease; Coronary Disease; Female; Hum | 1975 |
[Hemodynamic changes, renin activity and aldosterone excretion in chronic circulatory insufficiency].
Topics: Aldosterone; Blood Circulation; Chronic Disease; Coronary Disease; Hemodynamics; Humans; Potassium; | 1975 |
Rapid changes of atrial natriuretic peptide concentration during percutaneous transluminal coronary angioplasty.
Topics: Aldosterone; Angioplasty, Balloon, Coronary; Atrial Natriuretic Factor; Blood Pressure; Coronary Dis | 1991 |
[Changes in PTCA. A model of ischemia in humans].
Topics: Adenosine Triphosphate; Adult; Aged; Aldosterone; Angina Pectoris; Angioplasty, Balloon, Coronary; A | 1991 |
Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease.
Topics: Adult; Aged; Aldosterone; Captopril; Coronary Disease; Drug Tolerance; Female; Heart Failure; Hemody | 1990 |
Hemodynamic and hormone changes during induced ventricular tachycardia secondary to coronary artery disease.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Cardiac Pacing, Artificial; Coronary Disease; Electrop | 1989 |
[Changes in the hormonal profile in patients with ischemic heart disease during physical training].
Topics: Adult; Aldosterone; Coronary Disease; Exercise Therapy; Hormones; Humans; Hydrocortisone; Insulin; M | 1989 |
Hormonal supply during physical exercise in elderly patients with ischemic heart disease.
Topics: Adrenocorticotropic Hormone; Aged; Aldosterone; Coronary Disease; Endorphins; Exercise Test; Hemodyn | 1988 |
High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients.
Topics: Aldosterone; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Humans; Hypercholesterole | 1985 |
Effect of dilazep on hemoglobin-oxygen affinity in patients with ischemic heart disease.
Topics: 2,3-Diphosphoglycerate; Administration, Oral; Adult; Aged; Aldosterone; Angina Pectoris; Azepines; C | 1985 |
[Renin-angiotensin system in patients with circulatory insufficiency].
Topics: Aldosterone; Angiotensin II; Ascites; Coronary Disease; Diuretics; Edema; Endopeptidases; Humans; Ju | 1968 |
Role of catecholamines, aldosterone, potassium and lipids in pathophysiology and severity of myocardial infarction-a clinical and experimental study.
Topics: Aldosterone; Animals; Arteriosclerosis; Catecholamines; Coronary Disease; Dogs; Humans; Lipids; Myoc | 1974 |
Relationship of plasma aldosterone concentration to electrolytes and acid-base balance in blood after open cardiac surgery.
Topics: Acid-Base Equilibrium; Adult; Aldosterone; Aortic Valve; Blood; Carbon Dioxide; Cardiac Output; Coro | 1974 |
[Distribution of fluid between the cells and the extracellular media and mineralocorticoid function of the adrenal glands in cardiac insufficiency].
Topics: Adrenal Glands; Adult; Aldosterone; Antipyrine; Body Fluids; Chromatography, Paper; Coronary Disease | 1969 |
[Aldosterone and antidiuretic hormone in circulatory insufficiency].
Topics: Adolescent; Adult; Aged; Aldosterone; Coronary Disease; Female; Heart Failure; Humans; Male; Middle | 1969 |
[Research on arterial hypertension. Significance of aldosterone, catecholamines, amino acids and some electrolytes in compensated and decompensated cardiac lesions].
Topics: Adult; Aged; Aldosterone; Amino Acids; Catecholamines; Coronary Disease; Electrolytes; Female; Heart | 1970 |
[Aldosterone metabolism in renal artery stenosis].
Topics: Adult; Alanine Transaminase; Aldosterone; Coronary Disease; Female; Humans; Hypertension, Renal; Kid | 1967 |